Bioinformatics Analysis of Potential Key Genes in Trastuzumab-Resistant Gastric Cancer

Figure 3

Kaplan-Meier curves depicting the overall survival of all patients with gastric cancer (GC) (a) or HER2-positive (HER2+) gastric cancer (b) with high or low expression of ERBB2 or VIM ((c) GC, (d) HER2+ GC).

(a)

(b)

(c)

(d)